Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.42b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

Interim Management Statement

11 Nov 2021 09:41

RNS Number : 0912S
Mandarin Oriental International Ltd
11 November 2021
 

Announcement

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

11th November 2021 - Mandarin Oriental International Limited today issues its Interim Management Statement for the third quarter of 2021.

 

Overall trading conditions improved towards the end of the second quarter and this trend continued into the third quarter. Performance, however, varied by market depending on government actions to curtail the spread of COVID-19.

 

In Asia, most properties continued to rely on domestic business with international borders remaining effectively closed, and as a consequence both occupancy levels and average daily rates remained low. The exception was the Chinese mainland, where operations continued to benefit from strong demand in a large domestic market.

 

By contrast, the operating environment in both Europe and America improved substantially, with results benefitting from the relaxation of travel and freedom of movement restrictions.

 

On 22nd August 2021, the Group opened its second hotel in Turkey, Mandarin Oriental Bosphorus, Istanbul.

 

As a result of these improving conditions, together with continued significant government support in some markets, the Group recorded a marginal underlying profit (unaudited) in the third quarter, the first such positive performance since the fourth quarter of 2019. The management business continued its satisfactory performance, also recording an underlying profit in the third quarter.

 

The Group's financial position remains robust. Net debt at 30th September 2021 was US$568 million and the Group held US$162 million of cash reserves and US$296 million in available, committed debt facilities. Gearing was 11% of adjusted shareholders' funds.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing on the London Stock Exchange, with secondary listings in Bermuda and Singapore. It is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

James Riley (852) 2895 9288

Matthew Bishop (852) 2895 9288

Brunswick Group Limited

Sunitha Chalam (852) 3512 5050

 

This and other Group announcements can be accessed through the Internet at 'www.mandarinoriental.com'.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCKFLBFFFLZFBB
Date   Source Headline
13th Mar 20269:42 amRNSDirector/PDMR Shareholding
12th Mar 202611:09 amRNSDirector/PDMR Shareholding
10th Mar 202611:16 amRNSCompany Secretary Change
10th Mar 202611:16 amRNSCompany Secretary Change
10th Mar 202610:54 amRNS2025 Preliminary Results
10th Mar 202610:54 amRNS2025 Preliminary Results
5th Mar 202611:57 amRNS2025 PRELIMINARY RESULTS
4th Mar 202612:05 pmRNSDirector/PDMR Shareholding
4th Mar 202611:53 amRNSCorrection: Director/PDMR Shareholding
3rd Mar 202611:06 amRNS2025 PRELIMINARY RESULTS
27th Feb 202610:15 amRNSTotal Voting Rights
27th Feb 202610:12 amRNSJC&C - 2025 FY Results and Dividend
27th Feb 20269:46 amRNSPT Astra - 2025 Full Year Financial Statements
9th Feb 20269:37 amRNSDirector/PDMR Shareholding
4th Feb 202610:33 amRNSTransaction in Own Shares
4th Feb 202610:31 amRNSDirector/PDMR Shareholding
3rd Feb 202610:24 amRNSTransaction in Own Shares
2nd Feb 202610:36 amRNSTransaction in Own Shares
2nd Feb 202610:10 amRNSDirector/PDMR Shareholding
30th Jan 202610:31 amRNSTotal Voting Rights
30th Jan 202610:25 amRNSTransaction in Own Shares
30th Jan 20269:45 amRNSDirector/PDMR Shareholding
29th Jan 202610:27 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 202611:31 amRNSHolding(s) in Company
27th Jan 202610:29 amRNSTransaction in Own Shares
27th Jan 202610:25 amRNSDirector/PDMR Shareholding
26th Jan 202611:22 amRNSTransaction in Own Shares
23rd Jan 202610:21 amRNSTransaction in Own Shares
22nd Jan 20269:59 amRNSTransaction in Own Shares
21st Jan 202610:47 amRNSTransaction in Own Shares
21st Jan 20269:48 amRNSDirector/PDMR Shareholding
21st Jan 20269:39 amRNSGBP Exchange Rate for Scheme Value
20th Jan 202612:41 pmRNSCancellation of the Listings of Mandarin Oriental
20th Jan 20269:45 amRNSTransaction in Own Shares
20th Jan 20269:36 amRNSHolding(s) in Company
19th Jan 20261:45 pmRNSCompletion of Acquisition by Jardine Strategic
19th Jan 202610:24 amRNSTransaction in Own Shares
16th Jan 202611:05 amRNSDirector/PDMR Shareholding
16th Jan 202610:24 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSCourt Sanction of Scheme of Arrangement
15th Jan 202610:11 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20269:49 amRNSDirector/PDMR Shareholding
31st Dec 20257:23 amRNSTotal Voting Rights
31st Dec 20257:23 amRNSTotal Voting Rights
31st Dec 20257:22 amRNSUpdate on OCB Sale and Acquisition Timeline
31st Dec 20257:22 amRNSUpdate on OCB Sale and Acquisition Timeline
29th Dec 202511:11 amRNSTransaction in Own Shares
29th Dec 202511:11 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.